Acute erythroleukemia: diagnosis and management
Fabio P S Santos1, Carlos E Bueso-Ramos, Farhad Ravandi
1Department of Leukemia, University of Texas: MD Anderson Cancer Center, Houston, TX, USA.
Expert Review of Hematology
|November 25, 2010
Summary
Acute erythroleukemia, a rare acute myeloid leukemia subtype, has two forms: erythroid/myeloid and pure erythroid. Pure erythroid leukemia shows poor treatment response, necessitating novel therapeutic agents.
Area of Science:
- Hematology
- Oncology
- Leukemia Research
Background:
- Acute erythroleukemia (AEL) is a rare subtype of acute myeloid leukemia (AML).
- AEL classification has evolved over three decades.
- Two subtypes exist: erythroid/myeloid and pure erythroid.
Purpose of the Study:
- To summarize current knowledge on acute erythroleukemia.
- To highlight the distinct characteristics of AEL subtypes.
- To underscore the urgent need for new treatments for pure erythroid leukemia.
Main Methods:
- Review of existing literature and classification systems for AEL.
- Analysis of morphological and cytogenetic features differentiating AEL subtypes.
- Evaluation of treatment responses and survival data for AEL patients.
Main Results:
- Erythroid/myeloid AEL involves increased erythroid cells and myeloid blasts, often with dysplasia and complex karyotype.
- Pure erythroid leukemia is characterized by exclusive expansion of immature erythroid cells.
- Both subtypes present diagnostic and therapeutic challenges.
Conclusions:
- Pure erythroid leukemia is associated with a very poor response to current therapies.
- Suboptimal treatment outcomes necessitate the development of novel therapeutic agents for AEL.
- Further research is crucial for improving AEL patient management and survival rates.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...

